Quick Answer
STD tests produce both error types: false negatives dominate when testing precedes window periods (early HIV, early herpes IgG), while false positives cluster in low-prevalence populations and screening assays lacking confirmatory backup.
- Early-testing false negatives are the dominant error — biology hasn't produced detectable markers yet.
- Syphilis RPR generates biological false positives from autoimmune disease, pregnancy, and recent vaccinations.
- Herpes IgG carries notable false-positive rates at low index values — confirmatory testing advised.
- Modern NAAT for chlamydia/gonorrhea exceeds 98% specificity — false positives are genuinely rare there.
The Short Version, Structured
Every assay balances sensitivity against specificity, and population prevalence shapes predictive value: the same test performs differently screening high-risk versus low-risk groups. Confirmatory sequencing (screening then verification) exists precisely to manage this mathematics.
Received a positive? Verify before panicking.
Low-index herpes results and reactive-only syphilis screens deserve confirmation before life changes. Request titer levels, repeat testing, and differential diagnoses — good providers do this automatically.
Received a negative but symptoms persist?
Timing errors, wrong-site sampling, or non-STI causes explain most symptom-negative mismatches. Return for repeat testing and broader evaluation — persistence deserves pursuit, not dismissal.
Sources & Further Reading
- CDC — Sexually Transmitted Infections
- CDC STI Treatment Guidelines
- WHO — Sexually transmitted infections fact sheet
- MedlinePlus — Sexually Transmitted Diseases
Figures reflect CDC surveillance and WHO estimates; they are population statistics, not personal risk predictions.